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Ytomegalovirus (CMV) is the most common congenital and perinatal viral infection throughout the world, occurring in up to 3% of all newborn infants. [1] [2] [3] It is the leading cause of sensorineural hearing loss and the most frequently known viral cause of mental retardation, z,3 Infection rates in pregnant women have been reported to be as high as 50-80%. z, 3 The vertical transmission rate of CMV is approximately 40% with primary infections and 0.2-1.8% with recurrent infections, z Although intrauterine infection is common, only 10% of newborn infants will be symptomatic at birth, with 5-15% of asymptomatic infants subsequently demonstrating sensorineural hearing loss, mental retardation, microcephaly or motor defects by 2 years of age. [2] [3] [4] Typical cytomegalic inclusion disease in symptomatic infants has a mortality rate of 20-30%. 3 Cytomegalovirus is the largest member of the Herpesviridae family, and it has the biological properties of latency and reactivation. Its replicative cycle is divided into an immediate early, early, and late antigenic period. 4 (Fig. 1) . A similar product was obtained from the PCR positive control. Conversely, no amplification was obtained from either the negative meconium or negative PCR control.
Detection of CMV in the Meconium of
Infected Infants
The PCR amplification using amplimers specific to the MIE region of CMV yielded a 250-bp product from six patients who had CMV-positive urine. Amplification was also observed from the meconium of one patient who was negative for CMV by urine culture but had CMV-positive prenatal amniotic fluid by culture (Fig. 2) . The PCR amplification of the LA region of CMV yielded a 150-bp product from three out of six patients with positive urine cultures and the single patient with a negative urine culture but positive prenatal amniotic fluid culture (Fig. 3) . In both experiments PCR products of 250 bp and 150 bp were amplified from the CMV AD169 culture using the MIE and LA amplimers, respectively. Conversely, no amplification was observed in either the PCR or meconiumnegative controls.
The presence of CMV in three culture-negative patients born to CMV IgG-seropositive mothers was also examined using amplimers to the MIE and LA regions of CMV (Figs. 4, 5 
